SP101, a novel synthetic compound reduces the drug resistance of EGFR(T790M) and cancerous stemness in non-small cell lung carcinoma

Title:	SP101, a novel synthetic compound reduces the drug resistance of EGFR(T790M) and cancerous stemness in non-small cell lung carcinoma
Authors:	Chao, Jui-I 生物科技學系分子醫學與生物工程研究所 Department of Biological Science and Technology Institute of Molecular Medicine and Bioengineering
Issue Date:	1-Apr-2016
URI:	http://hdl.handle.net/11536/145847
ISSN:	0892-6638
Journal:	FASEB JOURNAL
Volume:	30
Issue:	1
Appears in Collections:	Articles